Ribosomal protein L21 pseudogene 26 (RPL21P26)

**RPL21P26 (Ribosomal protein L21 pseudogene 26)** is a processed pseudogene in the human genome, meaning it is a nonfunctional copy of the functional RPL21 gene, which encodes a protein component of the 60S large ribosomal subunit. While the parental RPL21 gene is involved in the synthesis of ribosomes and indirectly in protein synthesis, pseudogenes like RPL21P26 do not encode functional proteins and do not have a known biological function or involvement in disease or drug interactions[4][12][13].\n\n**Supporting details and clarifications:**\n- RPL21P26 is officially listed as a pseudogene in multiple genomics and nomenclature databases[4][12][13].\n- Pseudogenes are typically classified as “Other” in molecular family/taxonomy, as they do not encode functional proteins or have established roles as enzymes, receptors, or transporters.\n- There is no evidence from current sources that RPL21P26 is a therapeutic target, is involved in disease processes, or interacts with drugs.\n- The functional gene, RPL21, is a component of the ribosome but RPL21P26 is not functional and thus not considered a relevant biological or pharmacological target[13].\n- Multiple aliases are used, but "RPL21P26" appears consistently[4][13].\n\nNo errors or misspellings were detected for the described target, but it is important to note that pseudogenes generally do not serve as therapeutic targets.

Other names

RPL21_6_74RPL21P26